Combination-Based Drug Screening for Induced Oligodendrocyte Differentiation Enables Mechanistic Insight and Identifies Optimal Drug Pairs for Remyelination
Brittney A. Beyer(Spectral Labs (United States)), Luke L. Lairson(Scripps Research Institute)
Cited by 0
Related Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
|Science|2024|173
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation
|Cell stem cell|2010|134
Discovery of Small Molecules for the Reversal of T Cell Exhaustion
|Cell Reports|2019|49
Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancers
|European Journal of Medicinal Chemistry|2022|9
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|6